Published in J Clin Invest on December 01, 1982
Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J (1984) 13.20
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci U S A (2001) 2.48
microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease. Blood (2010) 2.34
Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax (2005) 1.85
Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol (2001) 1.61
Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. Blood (2010) 1.56
Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Br J Haematol (2006) 1.51
Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci U S A (1988) 1.51
Sickle cell membranes and oxidative damage. Biochem J (1986) 1.20
Red blood cell aggregation, aggregate strength and oxygen transport potential of blood are abnormal in both homozygous sickle cell anemia and sickle-hemoglobin C disease. Haematologica (2009) 1.19
Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood (2007) 1.17
Band 3 and glycophorin are progressively aggregated in density-fractionated sickle and normal red blood cells. Evidence from rotational and lateral mobility studies. J Clin Invest (1993) 1.16
Abnormal redox status of membrane-protein thiols in sickle erythrocytes. J Clin Invest (1985) 1.14
Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes. J Clin Invest (1984) 1.14
Sickle red cell-endothelium interactions. Microcirculation (2009) 1.12
Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respir Res (2001) 1.11
Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress. Am J Physiol Heart Circ Physiol (2008) 1.08
Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders. Curr Mol Med (2008) 1.07
Heinz bodies induce clustering of band 3, glycophorin, and ankyrin in sickle cell erythrocytes. J Clin Invest (1986) 1.07
Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture. J Clin Invest (1995) 1.02
Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue. Int J Impot Res (2010) 1.00
α-Thalassemia impairs the cytoadherence of Plasmodium falciparum-infected erythrocytes. PLoS One (2012) 0.99
Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease. Blood (2013) 0.98
Priapism in sickle-cell disease: a hematologist's perspective. J Sex Med (2011) 0.97
Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. Blood (2016) 0.96
A posttranslational modification of beta-actin contributes to the slow dissociation of the spectrin-protein 4.1-actin complex of irreversibly sickled cells. J Cell Biol (1995) 0.94
Total antioxidants status and some hematological values in sickle cell disease patients in steady state. J Natl Med Assoc (2007) 0.94
Altered phosphorylation of cytoskeleton proteins in sickle red blood cells: the role of protein kinase C, Rac GTPases, and reactive oxygen species. Blood Cells Mol Dis (2010) 0.94
Antisickling fetal hemoglobin reduces hypoxia-inducible factor-1α expression in normoxic sickle mice: microvascular implications. Am J Physiol Heart Circ Physiol (2012) 0.93
Sickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal response. PLoS One (2013) 0.89
Impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia. Rev Bras Hematol Hemoter (2013) 0.84
Association of oxidative stress markers with atherogenic index of plasma in adult sickle cell nephropathy. Anemia (2012) 0.84
Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy. Hematol Rep (2010) 0.84
Cysteine-iron promotes arginase activity by driving the Fenton reaction. Biochem Biophys Res Commun (2008) 0.83
Protective effect of flavonoids against reactive oxygen species production in sickle cell anemia patients treated with hydroxyurea. Rev Bras Hematol Hemoter (2013) 0.83
N-acetylcysteine reduces oxidative stress in sickle cell patients. Ann Hematol (2012) 0.82
The expanding role of oxygen free radicals in clinical medicine. West J Med (1986) 0.82
In vivo externalization of phosphatidylserine and phosphatidylethanolamine in the membrane bilayer and hypercoagulability by the lipid peroxidation of erythrocytes in rats. J Clin Invest (1985) 0.81
The proteome of sickle cell disease: insights from exploratory proteomic profiling. Expert Rev Proteomics (2010) 0.81
Sensitivity to cisplatin-induced mutations and elevated chromosomal aberrations in lymphocytes from sickle cell disease patients. Clin Exp Med (2008) 0.79
Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytes. Hemoglobin (2010) 0.79
Abnormality of phospholipid transverse diffusion in sickle erythrocytes. J Clin Invest (1985) 0.79
Phase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell Disease. PLoS One (2016) 0.78
Aged garlic extract therapy for sickle cell anemia patients. BMC Blood Disord (2002) 0.78
Association of Inflammatory Biomarker C-Reactive Protein, Lipid Peroxidation and Antioxidant Capacity Marker with HbF Level in Sickle Cell Disease Patients from Chattisgarh. Indian J Clin Biochem (2012) 0.77
Mitigating role of thymoquinone rich fractions from Nigella sativa oil and its constituents, thymoquinone and limonene on lipidemic-oxidative injury in rats. Springerplus (2014) 0.77
Microvascular oxygen consumption during sickle cell pain crisis. Blood (2014) 0.77
Effect of 1-chloro-2,4-dinitrobenzene on K+ transport in normal and sickle human red blood cells. J Physiol (2003) 0.77
Erythrocyte damage of crucian carp (Carassius auratus) caused by microcystin-LR: in vitro study. Fish Physiol Biochem (2012) 0.76
Membrane protein lesions in erythrocytes with Heinz bodies. J Clin Invest (1988) 0.76
Magnetic resonance imaging biomarkers of exercise-induced improvement of oxidative stress and inflammation in the brain of old high-fat-fed ApoE(-/-) mice. J Physiol (2016) 0.76
Proteomic analysis of ERK1/2-mediated human sickle red blood cell membrane protein phosphorylation. Clin Proteomics (2013) 0.76
Hematopoietic stem cell function in a murine model of sickle cell disease. Anemia (2012) 0.76
Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane flexibility in mice with sickle cell disease. Blood Cells Mol Dis (2014) 0.75
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension associated with hemolytic anemia. Ann Thorac Med (2014) 0.75
Possible links between sickle cell crisis and pentavalent antimony. Am J Trop Med Hyg (2012) 0.75
Chemical characterization and assessment of antioxidant potentiality of Streptocaulon sylvestre Wight, an endangered plant of sub-Himalayan plains of West Bengal and Sikkim. BMC Complement Altern Med (2015) 0.75
Superoxide-dependent production of hydroxyl radical catalyzed by iron-EDTA complex. FEBS Lett (1978) 5.12
Defective superoxide production by granulocytes from patients with chronic granulomatous disease. N Engl J Med (1974) 4.21
The generation of superoxide radical during the autoxidation of hemoglobin. J Biol Chem (1972) 2.83
Inside-out red cell membrane vesicles: preparation and purification. Science (1970) 2.61
Generation of hydroxyl radical by enzymes, chemicals, and human phagocytes in vitro. Detection with the anti-inflammatory agent, dimethyl sulfoxide. J Clin Invest (1979) 2.40
GENERATION OF HYDROGEN PEROXIDE IN ERYTHROCYTES BY HEMOLYTIC AGENTS. Biochemistry (1964) 2.37
Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest (1980) 2.34
In vivo inhibition of superoxide dismutase in mice by diethyldithiocarbamate. J Biol Chem (1976) 2.21
Irreversible deformation of the spectrin-actin lattice in irreversibly sickled cells. J Clin Invest (1976) 1.89
Abnormalities in membrane phospholipid organization in sickled erythrocytes. J Clin Invest (1981) 1.76
The susceptibility to autoxidation of human red cell lipids in health and disease. Br J Haematol (1972) 1.60
Activated oxygen and haemolysis. Br J Haematol (1975) 1.41
Denatured hemoglobin in sickle erythrocytes. J Clin Invest (1977) 1.38
On the state of the iron and the nature of the ligand in oxyhemoglobin. Proc Natl Acad Sci U S A (1970) 1.24
Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxidation of normal and sickled erythrocytes. Br J Haematol (1980) 1.22
Interaction of sickle cell hemoglobin with erythrocyte membranes. Proc Natl Acad Sci U S A (1981) 1.17
Abnormal vitamin E and glutathione peroxidase levels in sickle cell anemia: evidence for increased susceptibility to lipid peroxidation in vivo. J Lab Clin Med (1979) 1.08
Laboratory Diagnosis of sickling hemoglobinopathies. South Med J (1978) 1.05
Membrane-bound hemichrome in density-separated cohorts of normal (AA) and sickled (SS) cells. J Lab Clin Med (1982) 1.01
Prevalence of glucose-6-phosphate dehydrogenase deficiency in sickle-cell disease. N Engl J Med (1974) 1.01
The demonstration of ferrihemochrome intermediates in heinz body formation following the reduction of oxyhemoglobin A by acetylphenylhydrazone. Biochim Biophys Acta (1975) 0.99
Quantitative studies of ferritinlike iron in erythrocytes of thalassemia, sickle-cell anemia, and hemoglobin Hammersmith with Mössbauer spectroscopy. Proc Natl Acad Sci U S A (1979) 0.96
The interaction between (Ca2+ + Mg2+)-ATPase and the soluble activator (calmodulin) in erythrocytes containing haemoglobin S. Br J Haematol (1981) 0.82
Anion channel blockade: effects upon erythrocyte membrane calcium response. Am J Hematol (1980) 0.81
Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med (1994) 15.82
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 11.49
Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest (2000) 5.88
Circulating activated endothelial cells in sickle cell anemia. N Engl J Med (1997) 5.13
Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem (1992) 4.22
Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science (1982) 4.10
Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site. J Biol Chem (1984) 2.86
Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci U S A (1993) 2.77
Measuring circulating cell-derived microparticles. J Thromb Haemost (2004) 2.61
Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest (2000) 2.47
Generation of hydroxyl radical by enzymes, chemicals, and human phagocytes in vitro. Detection with the anti-inflammatory agent, dimethyl sulfoxide. J Clin Invest (1979) 2.40
Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest (1980) 2.34
The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro. Exp Cell Res (2004) 2.25
Haptoglobin: a natural bacteriostat. Science (1982) 2.23
Hemoglobin. A biologic fenton reagent. J Biol Chem (1984) 2.16
Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med (1980) 2.14
Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood (2000) 2.10
Multicellular oxidant defense in unicellular organisms. Proc Natl Acad Sci U S A (1992) 2.09
Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med (1993) 2.09
Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci U S A (1998) 2.02
Elevated erythrocyte calcium in sickle cell disease. Nature (1973) 1.97
Hereditary catalase deficiencies and increased risk of diabetes. Lancet (2000) 1.93
VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res (1999) 1.91
Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore) (1996) 1.90
Inflammatory responses to biomaterials. Am J Clin Pathol (1995) 1.89
Molecular basis of biomaterial-mediated foreign body reactions. Blood (2001) 1.87
Neonatal screening for sickle cell disease: a cost-effectiveness analysis. J Pediatr (1991) 1.81
Superoxide dismutase-rich bacteria. Paradoxical increase in oxidant toxicity. J Biol Chem (1987) 1.78
Phytic acid. A natural antioxidant. J Biol Chem (1987) 1.75
Ras transformation requires metabolic control by 6-phosphofructo-2-kinase. Oncogene (2006) 1.68
Reperfusion injury pathophysiology in sickle transgenic mice. Blood (2000) 1.65
Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol (2001) 1.61
Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol (2000) 1.60
CD36-positive stress reticulocytosis in sickle cell anemia. J Lab Clin Med (1996) 1.59
Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest (1998) 1.58
Antioxidant functions of phytic acid. Free Radic Biol Med (1990) 1.52
The adhesive sickle erythrocyte: cause and consequence of abnormal interactions with endothelium, monocytes/macrophages and model membranes. Clin Haematol (1985) 1.51
Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci U S A (1988) 1.51
Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb (1991) 1.49
Chlorinated urban water: a cause of dialysis-induced hemolytic anemia. Science (1973) 1.49
Erythropoietin for anemia of renal failure in sickle cell disease. N Engl J Med (1991) 1.46
Hemodialysis reduces inhibitory effect of plasma ultrafiltrate on LDL oxidation and subsequent endothelial reactions. Kidney Int (2006) 1.46
Effect of beta-globin gene cluster haplotype on the hematological and clinical features of sickle cell anemia. Am J Hematol (1991) 1.43
Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene. Blood (1986) 1.43
Skin color and nutrient photolysis: an evolutionary hypothesis. Science (1978) 1.43
alpha-Ketoacids scavenge H2O2 in vitro and in vivo and reduce menadione-induced DNA injury and cytotoxicity. Am J Physiol (1995) 1.38
Letter: Ascorbic acid-induced hemolysis in G-6-PD deficiency. Ann Intern Med (1975) 1.38
Molecular determinants of acute inflammatory responses to biomaterials. J Clin Invest (1996) 1.36
Natural responses to unnatural materials: A molecular mechanism for foreign body reactions. Mol Med (1999) 1.34
Intracellular targets in heme protein-induced renal injury. Kidney Int (1998) 1.33
Sexually transmitted diseases in South Africa. Genitourin Med (1996) 1.33
Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. Pharmacogenomics J (2007) 1.33
Lysosomal involvement in apoptosis. Redox Rep (2001) 1.31
Bacterial glutathione: a sacrificial defense against chlorine compounds. J Bacteriol (1996) 1.31
Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis. Angiogenesis (1999) 1.31
Malaria parasites adopt host cell superoxide dismutase. Science (1983) 1.30
Inflammatory responses to implanted polymeric biomaterials: role of surface-adsorbed immunoglobulin G. J Lab Clin Med (1993) 1.30
The relationship between red cell 2,3-diphosphoglycerate and levels of hemoglobin in the human. Proc Natl Acad Sci U S A (1968) 1.30
Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling. Oncogene (2009) 1.28
Membrane abnormalities of irreversibly sickled cells. Semin Hematol (1979) 1.27
Erythrocyte catalase. A somatic oxidant defense? J Clin Invest (1986) 1.24
Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood (1992) 1.24
Phagocytosis of sickle erythrocytes: immunologic and oxidative determinants of hemolytic anemia. Blood (1984) 1.23
A central role for plasminogen in the inflammatory response to biomaterials. J Thromb Haemost (2004) 1.22
Influence of treatment and response status on infection risk in multiple myeloma. Am J Med (1981) 1.21
Mild sickle cell disease. Clinical and laboratory studies. JAMA (1973) 1.21
Hemoglobin potentiates central nervous system damage. J Clin Invest (1987) 1.19
Survival at extreme altitude: protective effect of increased hemoglobin-oxygen affinity. Science (1974) 1.19
Alpha thalassaemia in adults with sickle-cell trait. Br J Haematol (1975) 1.18
Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait. J Clin Invest (1991) 1.17
Modulation of endothelial cell activation in sickle cell disease: a pilot study. Blood (2001) 1.17
Auto-oxidation and a membrane-associated 'Fenton reagent': a possible explanation for development of membrane lesions in sickle erythrocytes. Clin Haematol (1985) 1.16
Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate. J Clin Invest (1988) 1.15
Iron loading of endothelial cells augments oxidant damage. J Lab Clin Med (1990) 1.15
Clinical diversity of sickle cell anemia: genetic and cellular modulation of disease severity. Am J Hematol (1983) 1.14
Abnormal redox status of membrane-protein thiols in sickle erythrocytes. J Clin Invest (1985) 1.14
Hydroxyl radical formation by sickle erythrocyte membranes: role of pathologic iron deposits and cytoplasmic reducing agents. Blood (1991) 1.14
Degradation of biomaterials by phagocyte-derived oxidants. J Clin Invest (1993) 1.13
Leishmanial superoxide dismutase: a possible target for chemotherapy. Biochem Biophys Res Commun (1981) 1.13
Heme and the vasculature: an oxidative hazard that induces antioxidant defenses in the endothelium. Artif Cells Blood Substit Immobil Biotechnol (1994) 1.13
Blood cell abnormalities complicating the hypophosphatemia of hyperalimentation: erythrocyte and platelet ATP deficiency associated with hemolytic anemia and bleeding in hyperalimented dogs. J Lab Clin Med (1974) 1.12
Catalase activity and red cell metabolism. Adv Exp Med Biol (1972) 1.11
Effect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes. J Clin Invest (1993) 1.11
Sickle cell anemia: erythrokinetics, blood volumes, and a study of possible determinants of severity. Am J Hematol (1977) 1.11
Differential endothelial cell gene expression by African Americans versus Caucasian Americans: a possible contribution to health disparity in vascular disease and cancer. BMC Med (2011) 1.11
Cerebral ischemia enhances polyamine oxidation: identification of enzymatically formed 3-aminopropanal as an endogenous mediator of neuronal and glial cell death. J Exp Med (1998) 1.10
Bordetella adenylate cyclase toxin: entry of bacterial adenylate cyclase into mammalian cells. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 1.10
Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia. Blood (1984) 1.10
Hypohaptoglobinemia associated with familial epilepsy. J Exp Med (1985) 1.10
Antimalarial properties of orally active iron chelators. Blood (1988) 1.09
Superoxide dismutase amplifies organismal sensitivity to ionizing radiation. J Biol Chem (1989) 1.08
Hemoglobin Indianapolis (beta 112[G14] arginine). An unstable beta-chain variant producing the phenotype of severe beta-thalassemia. J Clin Invest (1979) 1.08
Human llamas: adaptation to altitude in subjects with high hemoglobin oxygen affinity. J Clin Invest (1978) 1.08
Host heme catabolism in drug-sensitive and drug-resistant malaria. J Lab Clin Med (1977) 1.08